Authors
Kohei Yamada, Masafumi Saito, Hiroyuki Nakashima, Masahiro Nakashima, Bradley M Kearney, Azusa Kato, Kazuma Mori, Ryohei Suematsu, Kazuya Yoshimoto, Jessica Müller, Harry Scherthan, Vijay K Singh, Manabu Kinoshita
Published in
Shock (Augusta, Ga.). Nov 16, 2026. Epub Nov 16, 2026.
Abstract
Radiation-combined burn injury (RCB), defined as concurrent irradiation and burn injury, is expected to be common in radiological or nuclear mass-casualty events and can be highly lethal. The mechanisms underlying the irradiation-burn interaction remain poorly understood, particularly whether it amplifies capillary leak and inflammatory mediator responses to drive early lethality. We examined whether repeated low-dose monophosphoryl lipid A (MPLA) preconditioning modulates this response and whether KC/CXCL1 contributes to vascular leakage.
Male C57BL/6J mice underwent 6 Gy whole-body irradiation followed 1 h later by a 20% total body surface area full-thickness burn. MPLA (10 µg/mouse) or vehicle was administered intraperitoneally on days -4 and -3. We assessed 30-day survival, hemoconcentration, intravascular FITC-albumin retention, intestinal barrier endpoints, and cytokine/chemokine responses. A separate exploratory experiment evaluated pre-irradiation anti-KC/CXCL1 antibody treatment.
Neither injury alone was lethal, whereas vehicle-treated RCB mice had 90% mortality (9 of 10 mice). Seven of these deaths occurred at 24-48 h after RCB. MPLA preconditioning increased 30-day survival from 10% to 80% (p = 0.0003) and eliminated deaths within 48 h. RCB induced hemoconcentration and tended to reduce FITC-albumin retention. Compared with vehicle-treated RCB mice, MPLA-preconditioned RCB mice had less hemoconcentration, significantly higher FITC-albumin retention, and lower mesenteric lymph node bacterial burden. MPLA preconditioning suppressed KC/CXCL1, which showed the largest absolute increase among measured cytokines/chemokines at 6 h. Anti-KC/CXCL1 antibody treatment significantly increased FITC-albumin retention at 6 h (p = 0.038).
MPLA preconditioning improved survival after RCB. It may attenuate early inflammatory and vascular abnormalities. Exploratory antibody-treatment findings suggest a possible contribution of KC/CXCL1 to early vascular albumin leakage, warranting further validation.
PMID:
43041153
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0